Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

MK-386 reduces sebum DHT levels.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

CDP is crucial for lung and hair follicle cell development.

The new compound may be a safer alternative to finasteride for prostate protection.

ALDOA levels drop in hair cells during hair loss.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

New compounds show promise as nonsteroidal treatments for hair loss.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

DGAT1 enzyme is crucial for healthy skin and hair by regulating retinoid levels.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The enzymes Aldh1a2 and Aldh1a3 are involved in making retinoic acid in hair follicles and have different roles in hair growth.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

A specific gene change in APCDD1 increases the risk of hair loss.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

β-sitosterol and brassicasterol may help treat hair loss.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.